Incyte Stock Market Capitalization
INCY Stock | USD 57.12 0.57 1.01% |
Incyte fundamentals help investors to digest information that contributes to Incyte's financial success or failures. It also enables traders to predict the movement of Incyte Stock. The fundamental analysis module provides a way to measure Incyte's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Incyte stock.
Incyte | Market Capitalization |
Incyte Market Capitalization Analysis
Incyte's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
More About Market Capitalization | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 34.3M | 44.6M | 38.3M | 36.4M | Total Assets | 4.9B | 5.8B | 6.8B | 7.1B |
Market Cap | = | Shares Outstanding | X | Share Price |
Current Incyte Market Capitalization | 12.7 B |
Most of Incyte's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incyte is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incyte Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Incyte is extremely important. It helps to project a fair market value of Incyte Stock properly, considering its historical fundamentals such as Market Capitalization. Since Incyte's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incyte's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incyte's interrelated accounts and indicators.
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition |
Incyte Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of Incyte is about 12.7 B. This indicator is about the same for the Biotechnology average (which is currently at 12.94 B) sector and 167.82% higher than that of the Health Care industry. The market capitalization for all United States stocks is 33.28% higher than that of the company.
Incyte Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incyte's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incyte could also be used in its relative valuation, which is a method of valuing Incyte by comparing valuation metrics of similar companies.Incyte is currently under evaluation in market capitalization category among related companies.
Incyte ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Incyte's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Incyte's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Incyte Fundamentals
Return On Equity | 0.13 | ||||
Return On Asset | 0.0646 | ||||
Profit Margin | 0.16 % | ||||
Operating Margin | 0.20 % | ||||
Current Valuation | 9.08 B | ||||
Shares Outstanding | 224.53 M | ||||
Shares Owned By Insiders | 1.57 % | ||||
Shares Owned By Institutions | 98.43 % | ||||
Number Of Shares Shorted | 7.91 M | ||||
Price To Earning | 19.17 X | ||||
Price To Book | 2.45 X | ||||
Price To Sales | 3.44 X | ||||
Revenue | 3.7 B | ||||
Gross Profit | 1.59 B | ||||
EBITDA | 904.74 M | ||||
Net Income | 597.6 M | ||||
Cash And Equivalents | 2.72 B | ||||
Cash Per Share | 12.24 X | ||||
Total Debt | 38.29 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 3.91 X | ||||
Book Value Per Share | 23.14 X | ||||
Cash Flow From Operations | 496.49 M | ||||
Short Ratio | 4.45 X | ||||
Earnings Per Share | 2.65 X | ||||
Price To Earnings To Growth | 0.73 X | ||||
Target Price | 75.41 | ||||
Number Of Employees | 2.52 K | ||||
Beta | 0.66 | ||||
Market Capitalization | 12.7 B | ||||
Total Asset | 6.78 B | ||||
Retained Earnings | 160.38 M | ||||
Working Capital | 3.41 B | ||||
Current Asset | 842.38 M | ||||
Current Liabilities | 168.01 M | ||||
Net Asset | 6.78 B |
About Incyte Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. Incyte Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2094 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incyte Piotroski F Score and Incyte Altman Z Score analysis. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Transaction History View history of all your transactions and understand their impact on performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.